Baseline characteristics of ROCKET AF patients according to major... | Download Table
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation | NEJM
Eliquis®| Pfizer India | Apixaban | Randomized Clinical Trial
Stroke Prevention in AF – A new Paradigm - ppt download
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial | Journal of the American Heart Association
Key results from the ROCKET AF renal impairment subanalysis (19) | Download Table
Recent Advances in Oral Anticoagulation Therapy for Patients with Atrial Fibrillation
A Comparison of RE-LY and ROCKET AF Trial Designs and Outcomes - ppt download
Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF - Heart Rhythm O2
Use of NOAC drugs in DC cardioversion for patients with non-valvular AF - The British Journal of Cardiology
Efficacy of rivaroxaban to prevent stroke in atrial fibriallation maintained in elderly - PACE-CME
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation | NEJM
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - Journal of Stroke and Cerebrovascular Diseases
RE-LY, ARISTOTLE, and ROCKET AF - Special Populations - Recent Advances in Oral Anticoagulation Therapy for Patients with Atrial Fibrillation
Factors Associated With Major Bleeding Events: Insights From the ROCKET AF Trial (Rivaroxaban Once-daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in
RE-LY, ROCKET AF, and ARISTOTLE trial design and conduct. | Download Table
Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J‐ROCKET AF Trials) in Asian Patients With Atrial Fibrillation | Journal of the American Heart Association
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF - The Lancet Neurology
Patient Demographics and Observations ROCKET AF PK/PD subset of... | Download Table
Prevention of Thromboembolism in Atrial Fibrillation: Factor XA and Thrombin Inhibitors | Basicmedical Key
ROCKET AF Clinical Trial Executive Committee Releases Secondary Analysis | DAIC
60371-5.fp.png "OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL | Journal of the American College of Cardiology")
OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL | Journal of the American College of Cardiology
ROCKET AF Results - Duke Clinical Research Institute
Safety Profile - NVAF | XARELTO® (rivaroxaban) HCP
Summary of key findings from the Phase III ROCKET AF trial of... | Download Table
Meta-analysis of large NOAC trials shows favourable risk/benefit ratio over warfarin - PACE-CME
